Your browser is no longer supported. Please, upgrade your browser.
Settings
AGTC Applied Genetic Technologies Corporation daily Stock Chart
AGTC [NASD]
Applied Genetic Technologies Corporation
Index- P/E220.59 EPS (ttm)0.02 Insider Own- Shs Outstand18.85M Perf Week-20.21%
Market Cap70.69M Forward P/E- EPS next Y-1.64 Insider Trans- Shs Float15.13M Perf Month-28.57%
Income0.40M PEG- EPS next Q-0.13 Inst Own70.70% Short Float1.77% Perf Quarter-27.88%
Sales39.50M P/S1.79 EPS this Y128.60% Inst Trans-7.27% Short Ratio1.22 Perf Half Y-47.92%
Book/sh6.38 P/B0.59 EPS next Y-157.10% ROA0.30% Target Price9.71 Perf Year-57.96%
Cash/sh6.72 P/C0.56 EPS next 5Y- ROE0.30% 52W Range3.50 - 10.85 Perf YTD-59.89%
Dividend- P/FCF- EPS past 5Y16.50% ROI-0.40% 52W High-65.44% Beta1.65
Dividend %- Quick Ratio4.60 Sales past 5Y105.30% Gross Margin- 52W Low7.14% ATR0.30
Employees72 Current Ratio4.60 Sales Q/Q-31.40% Oper. Margin4.60% RSI (14)35.32 Volatility9.99% 5.64%
OptionableYes Debt/Eq0.00 EPS Q/Q-263.70% Profit Margin1.00% Rel Volume2.86 Prev Close3.75
ShortableYes LT Debt/Eq0.00 EarningsSep 11 Payout0.00% Avg Volume218.39K Price3.75
Recom2.10 SMA20-15.82% SMA50-20.47% SMA200-41.96% Volume0 Change0.00%
Sep-14-17Reiterated Stifel Buy $15 → $12
May-11-17Reiterated Stifel Buy $18 → $15
Mar-15-17Initiated Rodman & Renshaw Buy $16
Nov-09-16Upgrade ROTH Capital Neutral → Buy
Nov-09-16Reiterated Wedbush Outperform $20 → $17
Sep-13-16Reiterated Wedbush Outperform $36 → $20
Sep-13-16Reiterated Stifel Buy $29 → $24
Sep-13-16Downgrade Wells Fargo Outperform → Market Perform
Sep-13-16Downgrade ROTH Capital Buy → Neutral
Sep-13-16Downgrade Cantor Fitzgerald Buy → Hold
Feb-09-16Reiterated Stifel Buy $32 → $29
Dec-04-15Initiated Wells Fargo Outperform
Jul-22-15Initiated Chardan Capital Markets Buy $25
Jul-06-15Reiterated Cantor Fitzgerald Buy $28 → $32
Nov-13-14Reiterated Stifel Buy $29 → $31
Nov-13-14Reiterated ROTH Capital Buy $25 → $34
Oct-03-14Initiated Stifel Buy $29
Sep-18-17 03:03PM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017 Capital Cube +5.63%
Sep-14-17 01:35AM  Edited Transcript of AGTC earnings conference call or presentation 13-Sep-17 12:00pm GMT Thomson Reuters StreetEvents -8.64%
Sep-13-17 10:29PM  Applied Genetic Technologies posts 4Q loss Associated Press -18.18%
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 GlobeNewswire
Sep-05-17 05:53PM  AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer GlobeNewswire
Aug-31-17 07:00AM  AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 13, 2017 GlobeNewswire
Aug-15-17 07:00AM  AGTC and the Foundation Fighting Blindness Announce Partnership Agreement GlobeNewswire
Aug-10-17 07:00AM  AGTC Files Investigational New Drug Application for the Treatment of X-linked Retinitis Pigmentosa Caused by Mutations in the RPGR Gene GlobeNewswire
Aug-08-17 07:00AM  AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16, 2017 GlobeNewswire
Aug-07-17 07:00AM  Research Published in Molecular Therapy Identifies Optimal Gene-based Therapeutic Construct for X-Linked Retinitis Pigmentosa GlobeNewswire
Aug-03-17 04:01PM  AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa GlobeNewswire
Aug-02-17 04:01PM  AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel GlobeNewswire
Jul-31-17 04:21PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 31, 2017 Capital Cube
Jul-13-17 03:24PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 13, 2017 Capital Cube
Jul-03-17 02:47PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 3, 2017 Capital Cube
Jun-19-17 02:51PM  ETFs with exposure to Applied Genetic Technologies Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:58AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-15-17 07:00AM  IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Development of AGTC-402 for the Treatment of CNGA3-deficient Achromatopsia GlobeNewswire
Jun-08-17 04:01PM  AGTC Announces Topline Safety Data for X-Linked Retinoschisis Phase 1/2 Study GlobeNewswire
07:00AM  Data Published in Molecular Therapy Demonstrate Five-Year Response Following a Single Dose of an Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency GlobeNewswire
May-11-17 07:00AM  AGTC Presents New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia and X-Linked Retinitis Pigmentosa at the American Society of Gene and Cell Therapy 20th Annual Meeting GlobeNewswire -5.04%
May-10-17 05:30PM  Applied Genetic Technologies posts 3Q loss Associated Press
04:08PM  AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 GlobeNewswire
10:30AM  Investor Network: Applied Genetic Technologies Corp. to Host Earnings Call Accesswire
May-09-17 07:01AM  AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting GlobeNewswire
May-02-17 07:00AM  AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 10, 2017 GlobeNewswire
May-01-17 03:33PM  ETFs with exposure to Applied Genetic Technologies Corp. : May 1, 2017 Capital Cube
Apr-20-17 07:00AM  AGTC to Present at the 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 GlobeNewswire
Apr-19-17 02:08PM  ETFs with exposure to Applied Genetic Technologies Corp. : April 19, 2017 Capital Cube
Apr-05-17 04:15PM  ETFs with exposure to Applied Genetic Technologies Corp. : April 5, 2017 Capital Cube
Mar-15-17 09:33AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q2, 2017 By the Numbers : March 15, 2017 Capital Cube
07:05AM  Coverage initiated on Applied Genetic Technologies by Rodman & Renshaw
Mar-09-17 06:02PM  Perrigo Launches First to Market OTC Equivalent of Rogaine Zacks
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat
Mar-06-17 10:46AM  Applied Genetic Technologies (AGTC) Shares March Higher, Can It Continue? Zacks -7.78%
Mar-03-17 07:00AM  AGTC to Present at the 29th Annual ROTH Conference on March 14, 2017 GlobeNewswire
Mar-02-17 04:02PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
09:06AM  Tenet Healthcare (THC) to Divest Operations to Amedisys Zacks
09:04AM  Molina Healthcare (MOH) Issues Revised Q4 & 2016 Results
08:40AM  Global Blood Therapeutics (GBT) in Focus: Stock Jumps 6.8%
Mar-01-17 08:30AM  Idera Pharmaceuticals (IDRA) Looks Good: Stock Up 13.3%
Feb-14-17 01:04PM  APPLIED GENETIC TECHNOLOGIES CORP Financials
Feb-10-17 04:01PM  AGTC Selected as Top Company in the University of Floridas 2017 Gator100 GlobeNewswire +6.57%
02:15PM  Seattle Genetics (SGEN) Loss Wider than Expected in Q4, Revenues Miss
Feb-08-17 07:15PM  Applied Genetic Technologies posts 2Q profit Associated Press
04:33PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
04:33PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
04:10PM  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 GlobeNewswire
07:07AM  Q2 2017 Applied Genetic Technologies Corp Earnings Release - After Market Close
Feb-02-17 07:15AM  AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 8, 2017 GlobeNewswire
Jan-24-17 07:00AM  AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual Deficits and Blindness GlobeNewswire
Jan-12-17 08:45AM  Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options
07:00AM  AGTC to Present at Phacilitate Cell & Gene Therapy World 2017 GlobeNewswire
Dec-22-16 12:47PM  ETFs with exposure to Applied Genetic Technologies Corp. : December 22, 2016
Dec-19-16 12:48PM  Big Changes to BioShares Biotech ETFs: Who's In, Who's Out? +5.71%
Dec-08-16 04:05PM  Applied Genetic Technologies Corp (AGTC): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-05-16 07:00AM  AGTC to Present at Upcoming Conferences GlobeNewswire +6.15%
Nov-29-16 03:02PM  ETFs with exposure to Applied Genetic Technologies Corp. : November 29, 2016
Nov-28-16 10:02AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2017 By the Numbers : November 28, 2016 -7.07%
Nov-18-16 01:20PM  These 5 Stocks Are Ready to Break Out
Nov-17-16 04:16PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:01PM  AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer GlobeNewswire
Nov-08-16 05:08PM  Applied Genetic Technologies posts 1Q profit
04:18PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:09PM  AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2016 GlobeNewswire
04:04PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2017 Applied Genetic Technologies Corp Earnings Release - After Market Close
Nov-03-16 07:00AM  AGTC to Present at the Stifel 2016 Healthcare Conference on November 15, 2016 GlobeNewswire
Oct-27-16 07:00AM  AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 8, 2016 GlobeNewswire -5.66%
Oct-19-16 04:01PM  AGTC Files Investigational New Drug Application for the Treatment of Achromatopsia Caused by Mutations in the CNGA3 Gene GlobeNewswire
Oct-18-16 09:37AM  ETFs with exposure to Applied Genetic Technologies Corp. : October 18, 2016
Oct-04-16 07:00AM  AGTC to Present at Upcoming Scientific Conferences GlobeNewswire
Sep-27-16 08:33AM  Eye-Catching Insider Selling at Ross Stores, Celgene Corporation, Copart; Two Other Companies Register Insider Buying at Insider Monkey
Sep-26-16 10:14AM  ETFs with exposure to Applied Genetic Technologies Corp. : September 26, 2016
Sep-20-16 09:05AM  Applied Genetic Technologies Is an Attractive Acquisition Target for Allergan or Biogen
Sep-16-16 09:20AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: 2016 By the Numbers : September 16, 2016
Sep-13-16 04:10PM  Applied Genetics stock suffers record plunge to record low at MarketWatch -31.77%
03:04PM  Here's Why Applied Genetic (AGTC) Stock Is Plummeting Today
01:49PM  Applied Genetic Technologies Corp (AGTC), Oasis Petroleum Inc. (OAS) & More: A Look at Five Stocks Falling on Tuesday at Insider Monkey
01:45PM  Why Applied Genetic Technologies Corp. Is Tanking Today at Motley Fool
10:15AM  ETFs with exposure to Applied Genetic Technologies Corp. : September 13, 2016
Sep-12-16 11:42PM  Edited Transcript of AGTC earnings conference call or presentation 12-Sep-16 9:00pm GMT +6.63%
04:39PM  Applied Genetic Technologies posts 4Q profit
04:34PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
04:22PM  AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2016 GlobeNewswire
04:17PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
07:07AM  Q4 2016 Applied Genetic Technologies Corp Earnings Release - After Market Close
05:35AM  Fed rate hike talk expected to jolt Wall Street investors; speakers eyed at CNBC
Sep-01-16 07:00AM  AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 12, 2016 GlobeNewswire
Aug-18-16 04:26PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements
04:01PM  AGTC Appoints Anne M. VanLent to its Board of Directors GlobeNewswire
Aug-09-16 07:00AM  AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16th, 2016 GlobeNewswire +5.33%
Aug-02-16 07:00AM  AGTC and the Medical College of Wisconsin Announce Publication of Natural History Study Data Evaluating Residual Photoreceptor Cone Status in Patients with CNGB3-associated Achromatopsia GlobeNewswire
Jul-21-16 07:00AM  AGTC Announces Presentations in Upcoming Scientific Conferences GlobeNewswire
Jul-13-16 04:34PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
Jul-07-16 07:00AM  AGTC to Present at the Cantor Fitzgerald Second Annual Healthcare Conference on July 13, 2016 GlobeNewswire
Jun-28-16 12:44PM  5 Best-Positioned Biotech Stocks on Brexit Volatility
Jun-09-16 07:00AM  AGTC to Host Research Day on June 21, 2016 in New York GlobeNewswire
Jun-07-16 07:00AM  AGTC Announces Orphan Medicinal Product Designation in the European Union for Gene Therapy to Treat X-linked Retinitis Pigmentosa GlobeNewswire
May-24-16 02:43PM  ETFs with exposure to Applied Genetic Technologies Corp. : May 24, 2016
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops genetic therapies to treat patients with inherited diseases. Its lead products consist of four ophthalmology development programs across three targets, including X linked retinoschisis (XLRS) that is in a Phase I/II clinical trials for the treatment of an inherited retinal disease; X-linked retinitis pigmentosa (XLRP), which is enrolling patients in a Phase I/II clinical trials; and achromatopsia (ACHM) that is enrolling patients in a Phase I/II clinical trials. Applied Genetic Technologies Corporation has collaboration agreements with Biogen MA, Inc.; 4D Molecular Therapeutics; and Synpromics Limited. The company was founded in 1999 and is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Magovcevic IvanaDirectorNov 16Buy9.633,00028,8753,000Nov 17 04:53 PM
Chulay Jeffrey D.VP and Chief Medical OfficerNov 01Sale7.051,0007,05220,400Nov 02 06:42 PM
Chulay Jeffrey D.VP and Chief Medical OfficerOct 19Option Exercise0.351,00035012,400Oct 21 06:03 PM
Shearman Mark SChief Scientific OfficerSep 22Buy8.873,00026,6023,000Sep 26 05:20 PM
Potter Stephen WSee RemarksSep 20Buy8.694003,4761,400Sep 27 05:12 PM